Humasis Co., Ltd. engages in developing rapid test kits and point-of-care testing instruments. The company was founded on June 12, 2000 and is headquartered in Anyang, South Korea.
The current price of 205470 is 1903 KRW — it has increased by 2.75% in the past 24 hours. Watch HUMASIS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange HUMASIS stocks are traded under the ticker 205470.
205470 stock is 4.54% volatile and has beta coefficient of 0.75. Track HUMASIS stock price on the chart and check out the list of the most volatile stocks — is HUMASIS there?
Yes, you can track HUMASIS financials in yearly and quarterly reports right on TradingView.
205470 stock has risen by 7.70% compared to the previous week, the month change is a 6.72% fall, over the last year HUMASIS has showed a 35.16% decrease.
205470 net income for the last quarter is −28.11 B KRW, while the quarter before that showed 1.25 B KRW of net income which accounts for −2.36 K% change. Track more HUMASIS financial stats to get the full picture.
Today HUMASIS has the market capitalization of 235.60 B, it has increased by 0.17% over the last week.
Like other stocks, 205470 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HUMASIS stock right from TradingView charts — choose your broker and connect to your account.
205470 reached its all-time high on Feb 3, 2022 with the price of 9113 KRW, and its all-time low was 285 KRW and was reached on Aug 6, 2019. View more price dynamics on 205470 chart. See other stocks reaching their highest and lowest prices.
As of May 2, 2024, the company has 107.00 employees. See our rating of the largest employees — is HUMASIS on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HUMASIS technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HUMASIS stock shows the sell signal. See more of HUMASIS technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HUMASIS EBITDA is −47.63 B KRW, and current EBITDA margin is −344.48%. See more stats in HUMASIS financial statements.